Attia Criteria for Evaluation of Pharyngitis

Attia Criteria Explained

The Attia criteria consist of four historical and physical examination findings used to predict the likelihood of Group A beta-hemolytic Streptococcal (GABHS) infection as the cause of pharyngitis in pediatric patients.

By effectively stratifying patients based on their risk, the Attia criteria enable more targeted and efficient use of resources, reducing unnecessary antibiotic use and focusing on those who truly need it. Ultimately, this leads to better patient outcomes, more judicious use of medical interventions, and improved overall healthcare quality for pediatric patients with sore throats.

The Attia criteria result interpretation is as follows:

• 0 points: Low likelihood of Streptococcal pharyngitis (Post-test probability of 12%);
• 1 to 3 points: Intermediate likelihood of Streptococcal pharyngitis (Post-test probability of 36%);
• 4 to 5 points: Higher likelihood of Streptococcal pharyngitis (Post-test probability of 79%).

Another relevant decision making tool for the evaluation of likelihood of GABHS infection in patients presenting with pharyngitis is the Centor Score. The score also serves the purpose of determining the probability of bacterial infection and to guide antibiotic therapy and further testing.

About the Original Study and Further Validation

The criteria was developed through a study involving patients aged 6 months to 18 years with sore throats in a pediatric emergency department, the criteria aim to help physicians more accurately perform testing and treatment.

Key predictors showed positive GABHS throat cultures in 65% of cases. This increased to 95% when a scarlatiniform rash was present.

A further validation study on a cohort of 587 patients, aged 1 to 18, in both emergency and outpatient settings, found that an Attia criteria score of 4 or 5 indicated a 79% probability of GABHS infection, while a score of 0 showed a 12% probability.

This helps stratify patients into low, intermediate, or high-risk groups for GABHS, guiding decisions on whether to test and treat.

However, a 2013 meta-analysis concluded that the Attia criteria do not offer sufficient discriminatory value for bedside use due to their limited ability to exclude GABHS in low-risk patients.

References

Original reference

Attia M, Zaoutis T, Eppes S, Klein J, Meier F. Multivariate predictive models for group A beta-hemolytic streptococcal pharyngitis in children. Acad Emerg Med. 1999;6(1):8-13.

Validation

Attia MW, Zaoutis T, Klein JD, Meier FA. Performance of a predictive model for streptococcal pharyngitis in children. Arch Pediatr Adolesc Med. 2001; 155(6):687-91.

Other reference

Steinhoff MC, Walker CF, Rimoin AW, Hamza HS. A clinical decision rule for management of streptococcal pharyngitis in low-resource settings. Acta Paediatr. 2005; 94(8):1038-42.

Le Marechal F, Martinot A, Duhamel A, Pruvost I, Dubos F. Streptococcal pharyngitis in children: a meta-analysis of clinical decision rules and their clinical variables. BMJ Open. 2013; 3(3):e001482.